cladribine / movectro

Based on this Merck press release , I removed cladribine (aka Movectro) from the phase 3 list. This situation is unique: the drug was approved in Australia and Russia, but based on their inability to gain approval in the US and EU, the company decided to stop development and pull it from the markets where it was already approved.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: